Self Report Cancers (datafile not available for download)
| File Name | Data as of | Population | Data collected | One row per | Rows |
|---|---|---|---|---|---|
| outc_src_cancer.dat | 5/10/2026 | SRC VPR | Ext2 | Participant | 62,557 |
ID - WHI Participant Common ID Col 1
TOTCANCER - Any Adjudicated or F33 Cancer Col 2 Usage Notes: This variable uses adjudicated cancer data through 6/15/2023 and self-report cancer data thereafter. It is defined as the first occurrence of any cancer (except non melanoma skin cancer) or a death due to cancer for adjudicated events or first occurrence of any cancer (except non melanoma skin cancer) for self-report events.
TOTCANCERDY - Days enrollment to Any Adjudicated or F33 Cancer Col 3
F33ANYCANCER - F33 Any Cancer Col 4 Usage Notes: Defined as the first occurrence of any F33 cancer (except non melanoma skin cancer) after 6/15/2023.
F33ANYCANCERDY - Days enrollment to F33 Any Cancer Col 5
F33BRAIN - F33 Brain Cancer Col 6 Usage Notes: Defined as the first self-reported Brain Cancer since 6/15/2023 for participants who did not previously have an adjudicated Brain Cancer.
F33BRAINDY - Days enrollment to F33 Brain Cancer Col 7
F33BLADDER - F33 Bladder Cancer Col 8 Usage Notes: Defined as the first self-reported Bladder Cancer since 6/15/2023 for participants who did not previously have an adjudicated Bladder Cancer.
F33BLADDERDY - Days enrollment to F33 Bladder Cancer Col 9
F33BREAST - F33 Breast Cancer Col 10 Usage Notes: Defined as the first occurrence of Invasive or In Situ Breast Cancer since 6/15/2023 for participants who did not previously have an adjudicated Invasive Breast Cancer.
F33BREASTDY - Days enrollment to F33 Breast Cancer Col 11
F33CERVICAL - F33 Cervical Cancer Col 12 Usage Notes: Defined as the first self-reported Cervical Cancer since 6/15/2023 for participants who did not previously have an adjudicated Cervical Cancer.
F33CERVICALDY - Days enrollment to F33 Cervical Cancer Col 13
F33COLORECTAL - F33 Colorectal Cancer Col 14 Usage Notes: Defined as the first occurrence of Colon Cancer, Rectosigmoid Cancer, or Rectum Cancer since 6/15/2023 for participants who did not previously have an adjudicated Colorectal Cancer.
F33COLORECTALDY - Days enrollment to F33 Colorectal Cancer Col 15
F33ENDMTRL - F33 Endometrial Cancer Col 16 Usage Notes: Defined as the first self-reported Endometrial Cancer since 6/15/2023 for participants who did not previously have an adjudicated Endometrial Cancer.
F33ENDMTRLDY - Days enrollment to F33 Endometrial Cancer Col 17
F33ESOPHAGUS - F33 Esophagus Cancer Col 18 Usage Notes: Defined as the first self-reported Esophagus Cancer since 6/15/2023 for participants who did not previously have an adjudicated Esophagus Cancer.
F33ESOPHAGUSDY - Days enrollment to F33 Esophagus Cancer Col 19
F33GALLBLDR - F33 Gallbladder Cancer Col 20 Usage Notes: Defined as the first self-reported Gallbladder Cancer since 6/15/2023 for participants who did not previously have an adjudicated Gallbladder Cancer.
F33GALLBLDRDY - Days enrollment to F33 Gallbladder Cancer Col 21
F33HODGKINS - F33 Lymphoma Hodgkins Col 22 Usage Notes: Defined as the first self-reported Lymphoma Hodgkins Cancer since 6/15/2023 for participants who did not previously have an adjudicated Lymphoma Hodgkins Cancer.
F33HODGKINSDY - Days enrollment to F33 Lymphoma Hodgkins Col 23
F33KIDNEY - F33 Kidney Cancer Col 24 Usage Notes: Defined as the first self-reported Kidney Cancer since 6/15/2023 for participants who did not previously have an adjudicated Kidney Cancer.
F33KIDNEYDY - Days enrollment to F33 Kidney Cancer Col 25
F33LIVER - F33 Liver Cancer Col 26 Usage Notes: Defined as the first self-reported Liver Cancer since 6/15/2023 for participants who did not previously have an adjudicated Liver Cancer.
F33LIVERDY - Days enrollment to F33 Liver Cancer Col 27
F33LEUKEMIA - F33 Leukemia Cancer Col 28 Usage Notes: Defined as the first self-reported Leukemia Cancer since 6/15/2023 for participants who did not previously have an adjudicated Leukemia Cancer.
F33LEUKEMIADY - Days enrollment to F33 Leukemia Cancer Col 29
F33LUNG - F33 Lung Cancer Col 30 Usage Notes: Defined as the first self-reported Lung Cancer since 6/15/2023 for participants who did not previously have an adjudicated Lung Cancer.
F33LUNGDY - Days enrollment to F33 Lung Cancer Col 31
F33MELANOMA - F33 Melanoma of the Skin Col 32 Usage Notes: Defined as the first self-reported Melanoma Cancer since 6/15/2023 for participants who did not previously have an adjudicated Melanoma Cancer.
F33MELANOMADY - Days enrollment to F33 Melanoma of the Skin Col 33
F33MMYELOMA - F33 Multiple Myeloma Col 34 Usage Notes: Defined as the first self-reported Multiple Myeloma Cancer since 6/15/2023 for participants who did not previously have an adjudicated Multiple Myeloma Cancer.
F33MMYELOMADY - Days enrollment to F33 Multiple Myeloma Col 35
F33GENITAL - F33 Genital Organs Cancer Col 36 Other Genital Organ Cancer Usage Notes: Defined as the first self-reported Genital Organs Cancer since 6/15/2023 for participants who did not previously have an adjudicated Genital Organs Cancer. Does not include ovary, endometrium or cervix.
F33GENITALDY - Days enrollment to F33 Genital Organs Cancer Col 37
F33OVARY - F33 Ovarian Cancer Col 38 Usage Notes: Defined as the first self-reported Ovary Cancer since 6/15/2023 for participants who did not previously have an adjudicated Ovary Cancer.
F33OVARYDY - Days enrollment to F33 Ovarian Cancer Col 39
F33PANCREAS - F33 Pancreas Cancer Col 40 Usage Notes: Defined as the first self-reported Pancreas Cancer since 6/15/2023 for participants who did not previously have an adjudicated Pancreas Cancer.
F33PANCREASDY - Days enrollment to F33 Pancreas Cancer Col 41
F33STOMACH - F33 Stomach Cancer Col 42 Usage Notes: Defined as the first self-reported Stomach Cancer since 6/15/2023 for participants who did not previously have an adjudicated Stomach Cancer.
F33STOMACHDY - Days enrollment to F33 Stomach Cancer Col 43
F33THYROID - F33 Thyroid Cancer Col 44 Usage Notes: Defined as the first self-reported Thyroid Cancer since 6/15/2023 for participants who did not previously have an adjudicated Thyroid Cancer.
F33THYROIDDY - Days enrollment to F33 Thyroid Cancer Col 45
F33LYMPHOMA - F33 Lymphoma Non Hodgkins Col 46 Usage Notes: Defined as the first self-reported Non Hodgkins Lymphoma Cancer since 6/15/2023 for participants who did not previously have an adjudicated Non Hodgkins Lymphoma Cancer.
F33LYMPHOMADY - Days enrolled to F33 Lymphoma Non Hodgkins Col 47
F33CANCOTHER - F33 Other/Unknown Cancer Col 48 Usage Notes: For occurrence of any Cancer site not listed above, defined as the first self-reported Cancer since 6/15/2023 for participants who did not previously have any other adjudicated Cancer.
F33CANCOTHERDY - Days enrollment to F33 Other/Unknown Cancer Col 49
LAST33DY - Days enrollment to last form 33/33D Col 50 Days from enrollment to last contact for outcomes information. Usage Notes: LAST33DY is calculated as the days from enrollment to the latest Form 33 during Extension Study 2. Because of the adjudication process, it is possible that there are some adjudicated events with days to event beyond LAST33DY. LAST33DY may be missing if the ppt had no form 33s entered for extension 2.
|
The purpose of this file is not for analysis. It is intended for planning purposes to provide an estimate of the number of cases that may be available for future projects. This file includes self-reported cancers since 6/15/2023 for SRC participants who are included in Virtual Pooled Registry Cancer Linkage System (VPR) searches, with the exception of the TOTCANCER and TOTCANCERDY variables (see TOTCANCER usage notes for details). These cancers are not being adjudicated, but will be available through VPR data at a future date.